C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
12/1999
12/16/1999	WO1999064048A1 Inhibitors of hiv reverse transcriptase
12/16/1999	WO1999064047A1 Novel antiviral compounds
12/16/1999	WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999	WO1999064038A1 Novel analgesic agents
12/16/1999	WO1999064037A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064033A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999	WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999	WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	WO1999063999A1 H1-histamine receptor antagonists
12/16/1999	WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	WO1999063988A1 Inhibitors of nitric oxide synthase
12/16/1999	WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999	WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	WO1999063940A2 INHIBITORS OF H+K+-ATPase
12/16/1999	WO1999063937A2 Multivalent macrolide antibiotics
12/16/1999	WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999	WO1999063929A2 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	CA2335339A1 .beta.-carboline compounds
12/16/1999	CA2321274A1 Novel antiviral compounds
12/16/1999	CA2321273A1 Novel analgesic agents
12/16/1999	CA2321190A1 Novel therapeutic agents that modulate enzymatic processes
12/16/1999	CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999	CA2321166A1 Multibinding inhibitors of topoisomerase
12/16/1999	CA2321162A1 Novel antibacterial compounds
12/16/1999	CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999	CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999	CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999	CA2320241A1 Multivalent macrolide antibiotics
12/16/1999	CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999	CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999	CA2319651A1 H1-histamine receptor antagonists
12/16/1999	CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999	CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999	CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999	CA2319495A1 Multibinding inhibitors of microsomal triglyceride transferase protein
12/16/1999	CA2319477A1 Inhibitors of h+k+-atpase
12/16/1999	CA2319474A1 Inhibitors of nitric oxide synthase
12/16/1999	CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999	CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999	CA2319120A1 Phosphodiesterase-v modulator drugs and their uses
12/16/1999	CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999	CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999	CA2318055A1 .beta.2-adrenergic receptor agonists
12/16/1999	CA2316999A1 Inhibitors of hiv reverse transcriptase
12/15/1999	EP0792252B1 Monomers and composition which can be crosslinked and crosslinked polymers
12/15/1999	EP0749434B1 Benzothiophene, benzofuran and indolethiazepinones, oxazepinones and diazepinones as inhibitors of cell adhesion and as inhibitors of hiv
12/14/1999	US6001850 Thienopyridine derivatives, their production and use
12/14/1999	US6001849 Furopyridine, thienopyridine pyrrolopyridine useful in controlling chemical synaptic transmission
12/14/1999	US6001830 Heterocyclic compounds
12/14/1999	CA2136007C Novel compound with platelet aggregation inhibitor activity
12/09/1999	WO1999063108A1 Novel peroxidase substrates and their use in catalyzed reporter deposition
12/09/1999	WO1999062909A2 Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents
12/09/1999	WO1999062908A2 Cell adhesion-inhibiting antinflammatory compounds
12/09/1999	WO1999062904A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999	WO1999062885A1 Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
12/09/1999	CA2333994A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999	CA2333770A1 Cell adhesion-inhibiting antinflammatory compounds
12/09/1999	CA2332957A1 Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
12/08/1999	EP0962451A2 Chiral catalysts for reduction of ketones and process for their preparation
12/07/1999	US5998461 Sleep disorders
12/07/1999	US5998444 Antiasthma agents; neurokinin antagonist
12/07/1999	US5998433 Condensed compounds, their production and use
12/01/1999	EP0850235B1 Quinolein-2(1h)-one derivatives as serotonin antagonists
12/01/1999	CN1237180A Thienotriazolodiazepine compounds and medical uses thereof
12/01/1999	CN1236780A Pyrazolopyrimidines and pyrazolotriazines
11/1999
11/30/1999	US5994391 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
11/30/1999	US5994274 Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
11/25/1999	WO1999059975A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999	WO1999059973A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999	WO1999059570A1 Protease inhibitors
11/25/1999	WO1999059526A2 Protease inhibitors
11/25/1999	CA2332531A1 Protease inhibitors
11/25/1999	CA2332492A1 Protease inhibitors
11/25/1999	CA2332279A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999	CA2332239A1 Fused tricyclic compounds which inhibit parp activity
11/24/1999	EP0958514A1 Novel photochromic heterocyclic fused indenonaphthopyrans
11/24/1999	EP0958296A1 Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
11/24/1999	CN1235968A Substituted tricyclics
11/24/1999	CN1046732C Enantioselective synthesis of 5,6-dihydro-(S)-4-(ethylamino)-(S)-6-methyl-4H-thieno [2,3-b] thiopyran-2-sulfonamide 7,7-dioxide and related compounds
11/24/1999	CN1046727C HIV protease inhibitors
11/24/1999	CN1046723C Tetracyclic compounds, pharmaceutical containing them and its use
11/23/1999	US5990132 Polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders
11/23/1999	US5990128 Administering an antagonist that binds to a human alpha-1c adrenergic receptor with a binding affinity at least 691-fold higher than the binding affinity with which the antagonist binds to a human alpha-1b adrenergic receptor
11/18/1999	WO1999058531A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999	WO1999058496A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999	WO1999058495A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999	CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/17/1999	EP0957109A2 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof
11/17/1999	EP0957092A1 Ring-closed dihydropyridines and their use in the preparation of pharmaceutical compositions
11/17/1999	CN1235156A New benzothiophene, benzofuran and indole compounds, process for their preparation and pharmaceutical compounds containing them
11/17/1999	CN1046522C Improved process for preparation of D-(+)-biotine intermediate product
11/17/1999	CN1046520C Bicyclic oxazine and thiazine oxazolidinone
11/17/1999	CN1046519C Oxazolyl- and thiazolylimidazo- and thienodiazepines and use as medicaments

1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 214